Peripheral blood changes
Leucopenia is common in patients with HIV infection and seems to correlate with the severity of the disease. Two hundred and twelve (23%) of a series of 925 HIV antibody positive patients at this hospital were leucopenic at some stage during their illness, and 88% ofpatients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC) were leucopenic at presentation.' Ofinterest is the contribution of lymphopenia, neutropenia, and granulocytopenia to the reduction of total number of white cells.
Lymphopenia in HIV disease is common, cells of the T helper phenotype being specifically depleted. In patients with AIDS and opportunistic infections immune function is more severely disturbed than in Accepted for publication 3 March 1988 patients with AIDS and opportunistic tumours.2 Care must be taken when interpreting the ratio of T helper to T suppressor cells. Only when there is lymphopenia does a decreased ratio indicate depletion of T helper cells. In patients with a normal lymphocyte count a decreased ratio might result either from T helper cell depletion or from T suppressor cell increase.
Mir found a 79% incidence of lymphopenia in Anaemia is commonly seen in patients with AIDS,' 48 often reflecting reticuloendothelial iron block and effects of treatment with drugs such as co-trimoxazole, pentamidine, foscarnet and more recently zidovudine (AZT). Blood transfusion is often necessary in patients with AIDS, especially in those receiving AZT, a drug which produces severe anaemia in a proportion of recipients.9 Forty nine (36%) of 138 patients treated with AZT at this hospital required blood transfusion at least once.'" Erythroid hypoplasia with severe anaemia has recently been described in patients with disseminated Mycobacterium avium-intracellulae (MAI) infection."
Whether bone marrow stem cells are infected with the HIV virus is as yet unknown but Zon suggested that erythropoiesis could be suppressed by the action of the retrovirus on progenitor cell proliferation or maturation. 8 Spivak raised the possibility of the anaemia in HIV disease being at least partly the result of suppression of erythropoiesis by cell to cell interaction. 4 The imbalance of T helper and T suppressor cell populations in AIDS lends credence to this theory.
Thrombocytopenia is a well recognised occurrence in patients infected with the HIV virus. It may be Costello immune in aetiology, related to drugs, or part of the pancytopenia often seen in ill patients with opportunistic infections.
The incidence ofthrombocytopenia has perhaps not been fully appreciated. The initial reluctance to put samples through a whole blood counter led to an evaluation of platelet numbers often being made on a blood film. Mild degrees of thrombocytopenia were quite likely overlooked. At this hospital we found a 13% incidence of thrombocytopenia (121 of 925 patients studied over 12 months) in patients who were at risk for HIV disease. Although most of the patients had either AIDS or ARC, 12% of the patients with thrombocytopenia were HIV antibody positive, and asymptomatic.
The diagnosis of immune thrombocytopenia is often made on clinical and bone marrow findings as platelet-associated immunoglobulin testing has not been widely used in high risk patients for reasons of safety. In patients with reduced platelet numbers and no splenomegaly, no drug treatment, and a marrow showing plentiful megakaryocytes, a presumptive diagnosis ofimmune thrombocytopenia may be made. The condition varies in HIV antibody positive patients, as in other patients with immune thrombocytopenia, from a well compensated state with only a mild reduction in platelet numbers to a severe condition with very low platelet counts.
The mechanism for immune thrombocytopenia has been studied by several workers in the United States. Walsh et al showed high concentrations of plateletassociated IgG and complement in homosexual patients with idiopathic thrombocytopenia (ITP).'2 These values were around four times higher than those seen in classic ITP and it is likely that they reflect deposition of immune complexes on the surface of the platelet. Raised concentrations of immune complexes are commonly found in patients with HIV disease, and interestingly, the homosexual control patients with normal platelet counts had concentrations of plateletassociated IgG and complement which were significantly higher than those of non-homosexual controls, suggesting that immune complex deposition on platelets may occur without large scale platelet destruction.
A true antiplatelet autoantibody, however, may coexist with immune complexes on the surface of the platelet. Strickler et al reported platelet membrane antibody in homosexual patients with ITP with reactivity against a 25000 molecular weight platelet membrane antigen, suggesting the presence of a 7S platelet antibody. '3 Furthermore, Van der Lelie eluted platelet bound immunoglobulin from his patients with HIV related disease that was shown to bind to normal platelets, indicating the presence of a specific platelet autoan- and may be associated with histochemical evidence of acid fast bacilli or fungal organisms.
The increased numbers of plasma cells and histiocytes often observed42829 is likely to be secondary to repeated infections. Some marrows show striking haemophagocytosis and this has previously been described in CMV and herpes simplex infection43' and in tuberculosis32 and histoplasmosis.33
The reticuloendothelial iron block seen in many patients with AIDS is a reflection of their clinical condition, with repeated episodes of infection caused by opportunistic organisms.
Bone marrow aspirates are often requested clinically to exclude Kaposi's sarcoma or non-Hodgkin's lymphoma, or for microbiological staining and culture. In disseminated infection MAI may be cultured from bone marrow aspirates and is associated with anaemia and red cell hypoplasia." Cryptococci and histoplasma have also been shown in marrow aspirates2934 and Hayman reported a patient with AIDS in whom Pneumocystis carinii organisms were 714 Costello shown in the bone marrow biopsy specimen. 35 We have recently seen a patient with AIDS who had extensive marrow disease with Leishmania.
The bone marrow cellularity in the patient infected with HIV does not always correlate with the peripheral blood findings. The commonly seen pancytopenia is often associated with an active, even hyperactive marrow, suggesting either dysmyelopoiesis or increased peripheral utilisation of blood cells. As previously discussed, immune mechanisms have been implicated in many cases of thrombocytopenia and in some cases of neutropenia.
It seems likely that although the bone marrow is obviously an affected organ in HIV disease, it is the target of many insults-drugs, opportunistic infections, and even the HIV retrovirus itself.
Lymphoma in HIV disease
Patients with HIV disease have an increased incidence of diffuse non-Hodgkin's lymphoma. This is often high grade and almost always of B cell origin.3637 A high incidence of extranodal and primary brain disease is observed, these features being similar to those seen in lymphomas developing in patients with congenital immunodeficiency such as Wiskott-Aldrich syndrome or ataxia telangiectasia, or in iatrogenic immunodeficiency states such as post-renal transplant. Although patients with non-Hodgkin's lymphoma associated with HIV infection may respond initially to combination chemotherapy, the relapse rate is high and the overall prognosis poor. Patients with other manifestations of AIDS at the time of development of non-Hodgkin's lymphoma seem to fare much worse. 36 The malignant lymphoma probably arises as a monoclonal outgrowth from a pool of proliferating B lymphocytes36 which have been stimulated by the Epstein-Barr virus38 and possibly also by other infective agents such as CMV.
We recently treated a patient with antibodies to HIV who developed acute lymphoblastic leukaemia of B cell origin (B-ALL),39 and Rossi4 has reported a similar case. It seems likely that B-ALL in addition to non-Hodgkin's lymphoma of B cell origin is a manifestation of AIDS in a patient with anti-HIV antibodies.
Hodgkin's disease has been reported in patients at risk for AIDS by several workers,4"3 though as yet the incidence is unclear.
Undoubtedly over the next few years we shall see many more patients with haematological abnormalities related to HIV disease, either directly by the retrovirus itself or indirectly as a complication of infection or treatment. The complex multisystem pathology in patients with AIDS is reflected in the almost universal finding of changes in the blood picture. The study of patients with less advanced disease might enable us to elucidate the cause of the haematological changes and to assess their clinical importance.
